A citation-based method for searching scientific literature

Kim Fox, Ian Ford, Philippe Gabriel Steg, Jean-Claude Tardif, Michal Tendera, Roberto Ferrari. N Engl J Med 2014
Times Cited: 277







List of co-cited articles
735 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study.
Karl Swedberg, Michel Komajda, Michael Böhm, Jeffrey S Borer, Ian Ford, Ariane Dubost-Brama, Guy Lerebours, Luigi Tavazzi. Lancet 2010
52

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.
Piotr Ponikowski, Adriaan A Voors, Stefan D Anker, Héctor Bueno, John G F Cleland, Andrew J S Coats, Volkmar Falk, José Ramón González-Juanatey, Veli-Pekka Harjola, Ewa A Jankowska,[...]. Eur Heart J 2016
25

2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology.
Gilles Montalescot, Udo Sechtem, Stephan Achenbach, Felicita Andreotti, Chris Arden, Andrzej Budaj, Raffaele Bugiardini, Filippo Crea, Thomas Cuisset, Carlo Di Mario,[...]. Eur Heart J 2013
23


Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina.
Jean-Claude Tardif, Ian Ford, Michal Tendera, Martial G Bourassa, Kim Fox. Eur Heart J 2005
338
19


Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial.
Michael Böhm, Karl Swedberg, Michel Komajda, Jeffrey S Borer, Ian Ford, Ariane Dubost-Brama, Guy Lerebours, Luigi Tavazzi. Lancet 2010
584
18

Atrial fibrillation associated with ivabradine treatment: meta-analysis of randomised controlled trials.
Ruairidh I R Martin, Oksana Pogoryelova, Mauro Santibáñez Koref, John P Bourke, M Dawn Teare, Bernard D Keavney. Heart 2014
91
18



Meta-analysis: beta-blocker dose, heart rate reduction, and death in patients with heart failure.
Finlay A McAlister, Natasha Wiebe, Justin A Ezekowitz, Alexander A Leung, Paul W Armstrong. Ann Intern Med 2009
341
15

The Clinical Use of Ivabradine.
Jacob S Koruth, Anuradha Lala, Sean Pinney, Vivek Y Reddy, Srinivas R Dukkipati. J Am Coll Cardiol 2017
51
29

β-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease.
Sripal Bangalore, Gabriel Steg, Prakash Deedwania, Kevin Crowley, Kim A Eagle, Shinya Goto, E Magnus Ohman, Christopher P Cannon, Sidney C Smith, Uwe Zeymer,[...]. JAMA 2012
278
14

Effects of selective heart rate reduction with ivabradine on left ventricular remodelling and function: results from the SHIFT echocardiography substudy.
Jean-Claude Tardif, Eileen O'Meara, Michel Komajda, Michael Böhm, Jeffrey S Borer, Ian Ford, Luigi Tavazzi, Karl Swedberg. Eur Heart J 2011
199
12

Expert consensus document: A 'diamond' approach to personalized treatment of angina.
Roberto Ferrari, Paolo G Camici, Filippo Crea, Nicolas Danchin, Kim Fox, Aldo P Maggioni, Athanasios J Manolis, Mario Marzilli, Giuseppe M C Rosano, José L Lopez-Sendon. Nat Rev Cardiol 2018
56
21

Current-dependent block of rabbit sino-atrial node I(f) channels by ivabradine.
Annalisa Bucchi, Mirko Baruscotti, Dario DiFrancesco. J Gen Physiol 2002
187
11

Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease.
Ariel Diaz, Martial G Bourassa, Marie-Claude Guertin, Jean-Claude Tardif. Eur Heart J 2005
530
11


Clinical outcomes with β-blockers for myocardial infarction: a meta-analysis of randomized trials.
Sripal Bangalore, Harikrishna Makani, Martha Radford, Kamia Thakur, Bora Toklu, Stuart D Katz, James J DiNicolantonio, P J Devereaux, Karen P Alexander, Jorn Wetterslev,[...]. Am J Med 2014
140
10

Heart rate and cardiovascular mortality: the Framingham Study.
W B Kannel, C Kannel, R S Paffenbarger, L A Cupples. Am Heart J 1987
931
10

Effect of early treatment with ivabradine combined with beta-blockers versus beta-blockers alone in patients hospitalised with heart failure and reduced left ventricular ejection fraction (ETHIC-AHF): A randomised study.
Francisco J Hidalgo, Manuel Anguita, Juan C Castillo, Sara Rodríguez, Laura Pardo, Enrique Durán, José J Sánchez, Carlos Ferreiro, Manuel Pan, Dolores Mesa,[...]. Int J Cardiol 2016
49
20

2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes.
Juhani Knuuti, William Wijns, Antti Saraste, Davide Capodanno, Emanuele Barbato, Christian Funck-Brentano, Eva Prescott, Robert F Storey, Christi Deaton, Thomas Cuisset,[...]. Eur Heart J 2020
10

Heart rate at baseline influences the effect of ivabradine on cardiovascular outcomes in chronic heart failure: analysis from the SHIFT study.
Michael Böhm, Jeffrey Borer, Ian Ford, Jose R Gonzalez-Juanatey, Michel Komajda, Jose Lopez-Sendon, Jan-Christian Reil, Karl Swedberg, Luigi Tavazzi. Clin Res Cardiol 2013
141
9


Resting heart rate in cardiovascular disease.
Kim Fox, Jeffrey S Borer, A John Camm, Nicolas Danchin, Roberto Ferrari, Jose L Lopez Sendon, Philippe Gabriel Steg, Jean-Claude Tardif, Luigi Tavazzi, Michal Tendera. J Am Coll Cardiol 2007
630
9

Effect of ivabradine in patients with heart failure with preserved ejection fraction: the EDIFY randomized placebo-controlled trial.
Michel Komajda, Richard Isnard, Alain Cohen-Solal, Marco Metra, Burkert Pieske, Piotr Ponikowski, Adriaan A Voors, Fabienne Dominjon, Cécile Henon-Goburdhun, Matthieu Pannaux,[...]. Eur J Heart Fail 2017
96
9



Ivabradine in combination with beta-blocker improves symptoms and quality of life in patients with stable angina pectoris: results from the ADDITIONS study.
Karl Werdan, Henning Ebelt, Sebastian Nuding, Florian Höpfner, Guido Hack, Ursula Müller-Werdan. Clin Res Cardiol 2012
53
15



Selective Heart Rate Reduction With Ivabradine Increases Central Blood Pressure in Stable Coronary Artery Disease.
Stefano F Rimoldi, Franz H Messerli, David Cerny, Steffen Gloekler, Tobias Traupe, Stéphane Laurent, Christian Seiler. Hypertension 2016
25
32

Optimal medical therapy with or without PCI for stable coronary disease.
William E Boden, Robert A O'Rourke, Koon K Teo, Pamela M Hartigan, David J Maron, William J Kostuk, Merril Knudtson, Marcin Dada, Paul Casperson, Crystal L Harris,[...]. N Engl J Med 2007
8

Clinical efficacy of ivabradine in patients with inappropriate sinus tachycardia: a prospective, randomized, placebo-controlled, double-blind, crossover evaluation.
Riccardo Cappato, Serenella Castelvecchio, Cristian Ricci, Elisabetta Bianco, Laura Vitali-Serdoz, Tomaso Gnecchi-Ruscone, Mario Pittalis, Luigi De Ambroggi, Mirko Baruscotti, Maddalena Gaeta,[...]. J Am Coll Cardiol 2012
91
7


Efficacy and safety of ivabradine in patients with chronic systolic heart failure according to blood pressure level in SHIFT.
Michel Komajda, Michael Böhm, Jeffrey S Borer, Ian Ford, Michele Robertson, Athanasios J Manolis, Luigi Tavazzi, Karl Swedberg. Eur J Heart Fail 2014
45
15

Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trial.
Philip A Poole-Wilson, Jacobus Lubsen, Bridget-Anne Kirwan, Fred J van Dalen, Gilbert Wagener, Nicolas Danchin, Hanjörg Just, Keith A A Fox, Stuart J Pocock, Tim C Clayton,[...]. Lancet 2004
346
7

Efficacy Profile of Ivabradine in Patients with Heart Failure plus Angina Pectoris.
Jeffrey S Borer, Karl Swedberg, Michel Komajda, Ian Ford, Luigi Tavazzi, Michael Böhm, Christophe Depre, Yuna Wu, Juan Maya, Fabienne Dominjon. Cardiology 2017
10
70

Coronary microvascular dysfunction: an update.
Filippo Crea, Paolo G Camici, Cathleen Noel Bairey Merz. Eur Heart J 2014
332
7


2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
Clyde W Yancy, Mariell Jessup, Biykem Bozkurt, Javed Butler, Donald E Casey, Mark H Drazner, Gregg C Fonarow, Stephen A Geraci, Tamara Horwich, James L Januzzi,[...]. J Am Coll Cardiol 2013
7

Improvement of regional myocardial blood flow and function and reduction of infarct size with ivabradine: protection beyond heart rate reduction.
Gerd Heusch, Andreas Skyschally, Petra Gres, Patrick van Caster, Dustin Schilawa, Rainer Schulz. Eur Heart J 2008
111
7


Heart rate as a prognostic factor for coronary heart disease and mortality: findings in three Chicago epidemiologic studies.
A R Dyer, V Persky, J Stamler, O Paul, R B Shekelle, D M Berkson, M Lepper, J A Schoenberger, H A Lindberg. Am J Epidemiol 1980
445
7

Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials.
John G F Cleland, Karina V Bunting, Marcus D Flather, Douglas G Altman, Jane Holmes, Andrew J S Coats, Luis Manzano, John J V McMurray, Frank Ruschitzka, Dirk J van Veldhuisen,[...]. Eur Heart J 2018
211
7


Heart Rate reduction by IVabradine for improvement of ENDothELial function in patients with coronary artery disease: the RIVENDEL study.
Fabio Mangiacapra, Iginio Colaiori, Elisabetta Ricottini, Francesco Balducci, Antonio Creta, Chiara Demartini, Giorgio Minotti, Germano Di Sciascio. Clin Res Cardiol 2017
21
33

Pacemaker mechanisms in cardiac tissue.
D DiFrancesco. Annu Rev Physiol 1993
564
7

Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): a multicentre, randomised, double-blind, placebo-controlled trial.
Giora Weisz, Philippe Généreux, Andres Iñiguez, Aleksander Zurakowski, Michael Shechter, Karen P Alexander, Ovidiu Dressler, Anna Osmukhina, Stefan James, E Magnus Ohman,[...]. Lancet 2016
69
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.